(Investor.gov)
A new survey shows 60 percent of type-2 diabetes patients in the U.S. who currently use insulin say they would prefer switching to a less expensive bio-similar insulin if such an agent became available. Decision Resources, a health care industry research firm, conducted the survey of diabetes patients in September 2010.
Decision Resources reports most surveyed type-2 diabetes patients indicate that they have some form of prescription coverage associated with their insurance, but patients taking insulin still say that they feel their disease is a greater financial burden compared to other types of patients.
The majority of insulin users surveyed say they are also taking at least one oral anti-diabetic, resulting in multiple co-payments each month, increasing the monthly out-of-pocket cost for these patients. The cost of test strips and glucose meters to check blood glucose levels twice a day adds another cost to patients.
The report, Patient Forum in Type-2 Diabetes: Patients Resistance to Injectable Agents May Cause Challenges for Emerging GLP-1 Analogues, is based on a survey of 502 U.S. diabetes patients. To take part in the survey, patients must have been between 18 and 80 years old, been diagnosed with type-2 diabetes by a physician, and been taking prescription medication for their diabetes at the time.
Related: Disposable Insulin Device Gets FDA Clearance
* * *
RSS - Posts
[…] This post was mentioned on Twitter by Alltop Science. Alltop Science said: Survey: Type-2 Diabetes Patients Would Switch from Insulin http://bit.ly/hyAl9d Science.alltop […]
Diabetes is a condition where body blood sugar levels are higher than the normal which may lead to other complications in the body. A high blood sugar level or hyperglycemia may lead to kidney diseases…neurological complication and hypertension etc. All this can be avoided by keeping your blood sugar levels in control by a proper dietary supervision.
[…] Read more: Survey: Type-2 Diabetes Patients Would Switch from Insulin […]